Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Today's Medical News

Hematology & Oncology

ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer

For men with advanced prostate cancer, the oral gonadotropin-releasing hormone (GnRH) antagonist relugolix maintains testosterone suppression compared with the GnRH agonist leuprolide, while enzalutamide is associated with improved survival versus placebo in nonmetastatic, castration-resistant prostate cancer, according to two studies published online May 29 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology Virtual Scientific Program.

Nephrology

Inequity Found in Access to Transplant With Universal Health Care

Patient factors account for much of the variation in access to kidney transplantation in the United Kingdom, according to a study published online May 28 in the Clinical Journal of the American Society of Nephrology.

Conference Highlights

April 27 2020 - April 28 2020American Association for Cancer Research, April 27-28
March 28 2020 - March 30 2020American College of Cardiology, March 28-30
March 28 2020 - March 31 2020The Endocrine Society, March 28-31
February 19 2020 - February 21 2020American Stroke Association, Feb. 19-21
December 10 2019 - December 14 2019CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 10-14

Monthly Briefings